Examining Medical Product Manufacturer Communications.

Guidance for industry : patient-reported outcome measures, use in medical product development to support labeling claims.
Published: (2006)

Food labeling : FDA needs to better leverage resources, improve oversight, and effectively use available data to help consumers select healthy foods : report to the Chair, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, House of Representatives.
Published: (2008)

Food labeling : FDA needs to reassess its approach to protecting consumers from false or misleading claims : report to congressional committees.
Published: (2011)

Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling.
Published: (2014)

Medical devices: FDA has begun building an active postmarket surveillance system : report to congressional requesters.
Published: (2024)

Examining FDA's Role in the Regulation of Genetically Modified Food Ingredients.
Published: (2014)

Protecting Seniors from Medication Labeling Mistakes.
Published: (2013)

Food and Drug Administration's food labeling regulation : its effect on small business : hearings before the Subcommittee on Special Small Business Problems of the Committee on Small Business, House of Representatives, Ninety-fifth Congress, second session ... July 13, August 3, 1977, and March 15, 1978.
Published: (1978)

Commission on Dietary Supplement Labels report to the President, Congress, and the Secretary of the Department of Health and Human Services.
Published: (1997)

Medical product regulatory affairs : pharmaceuticals, diagnostics, medical devices /
by: Tobin, John J., Dr, et al.
Published: (2014)

"Man-in-the-plant", FDA's failure to regulate deceptive drug labeling : hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978.
Published: (1978)

Drugs : many consumers at risk due to poor labeling, lax federal regulation, and a review process that present special problems for the elderly : joint hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business and the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, Washington, DC, April 28, 1992.
Published: (1993)

FDA to consider whether and how to lower permissible nicotine levels in cigarettes /
by: Barry, Matthew B.
Published: (2018)

Drug legislation : hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-eighth Congress, first session, on drug labeling and advertising, H.R. 1554, new drug application, H.R. 3605, July 25, 1983 : drug abuse, Quaaludes, H.R. 1055, H.R. 1097, October 3, 1983.
Published: (1983)

Medical Devices : Protecting Patients and Promoting Innovation.
Published: (2011)

The FDA medical device user fee program /
by: Johnson, Judith A. (Judith Ann), 1957-
Published: (2020)

Food and Drug Administration Amendments Act of 2007 : report together with additional views (to accompany H.R. 2900) (including cost estimate of the Congressional Budget Office).
Published: (2007)

Amending the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients : report together with additional views (to accompany S. 2394).
Published: (2002)

Notice to manufacturers of medicinal preparations.
Published: (1931)

Use of symbols on labels and in labeling of in vitro diagnostic devices intended for professional use.
Published: (2004)

Reauthorization of MDUFA : What It Means for Jobs, Innovation, and Patients.
Published: (2012)

Medical device user fees : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session, on H.R. 4728, a bill to amend the Federal Food, Drug, and Cosmetic Act to authorize a device application fee, and for other purposes, July 14, 1994.
Published: (1994)

Examining Federal Regulation of Mobile Medical Apps and Other Health Software.
Published: (2013)

Hazardous to our health? : FDA regulation of health care products /
Published: (1995)

Foods, Drugs, and Cosmetics : hearings before the United States Senate Committee on Commerce, Subcommittee on S. 5, Seventy-Fourth Congress, first session, on Mar. 2, 8, 9, 1935.
Published: (1935)

Safe and Accurate Food Labeling Act of 2015 : report together with dissenting views (to accompany H.R. 1599) (including cost estimate of the Congressional Budget Office).
Published: (2015)

Making Objective Drug Evidence Revisions for New Labeling Act of 2020 : report (to accompany H.R. 5668) (including cost estimate of the Congressional Budget Office).
Published: (2020)

Examining the Increase in Drug Shortages.
Published: (2011)

Examining FDA's Medical Device User Fee Program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 28, 2017.
Published: (2018)

The law and regulation of medicines and medical devices /
by: Feldschreiber, Peter
Published: (2021)

Product labeling and the law /
by: Hicks, Lawrence E.
Published: (1974)

Medical devices and the FDA : regulation, user fees and tort claims /
Published: (2013)

Guidance for industry : product name placement, size, and prominence in advertising and promotional labeling.
Published: (1999)

The Nutrition quality index : an instrument for communicating nutrition information to consumers /
Published: (1993)

Guidance for industry : dosage and administration section of labeling for human prescription drug and biological products, content and format.
Published: (2007)

Food, drug, cosmetic, and device enforcement amendments : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2597, a bill to amend the Federal Food, Drug, and Cosmetic Act to enhance the enforcement authority of the Food and Drug Administration, July 17, 1991.
Published: (1991)